Works by Basu, Ellen

Results: 27

Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1106597

By:

Fong, Christina;
Kushner, Brian H.;
Di Giannatale, Angela;
Gundem, Gunes;
Li, Shanita;
Roberts, Stephen S.;
Basu, Ellen M.;
Price, Anita;
Cheung, Nai-Kong V.;
Modak, Shakeel

Publication type:

Article

Evolutionary Strategies AI Addresses Multiple Technical Challenges in Deep Learning Deployment: Proof-of-Principle Demonstration for Neuroblastoma Brain Metastasis Detection.

Published in:

Journal of Digital Imaging, 2024, v. 37, n. 6, p. 2920, doi. 10.1007/s10278-024-01165-z

By:

Purkayastha, Subhanik;
Shalu, Hrithwik;
Gutman, David;
Holodny, Andrei;
Modak, Shakeel;
Basu, Ellen;
Kushner, Brian;
Kramer, Kim;
Haque, Sofia;
Stember, Joseph N.

Publication type:

Article

Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease.

Published in:

EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01127-0

By:

Prasad, Kavya;
Serencsits, Brian E.;
Chu, Bae P.;
Dauer, Lawrence T.;
Donzelli, Maria;
Basu, Ellen;
Kramer, Kim;
Pandit-Taskar, Neeta

Publication type:

Article

Ovarian function in female survivors of high‐risk neuroblastoma.

Published in:

Pediatric Blood & Cancer, 2024, v. 71, n. 9, p. 1, doi. 10.1002/pbc.31181

By:

Jimenez‐Kurlander, Lauren;
DeRosa, Amelia;
Kostrzewa, Caroline E.;
Moskowitz, Chaya S.;
Bogardus, Kimberly;
Antal, Zoltan;
Wolden, Suzanne;
La Quaglia, Michael P.;
Basu, Ellen M.;
Cardenas, Fiorella Iglesias;
Kramer, Kim;
Kushner, Brian H.;
Cheung, Nai‐Kong V.;
Modak, Shakeel;
Friedman, Danielle Novetsky

Publication type:

Article

Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.

Published in:

Pediatric Blood & Cancer, 2023, v. 70, n. 2, p. 1, doi. 10.1002/pbc.30075

By:

Tringale, Kathryn R.;
Wolden, Suzanne L.;
Casey, Dana L.;
Kushner, Brian H.;
Luo, Leo;
Pandit‐Taskar, Neeta;
Souweidane, Mark;
Cheung, Nai‐Kong V.;
Modak, Shakeel;
Basu, Ellen M.;
Kramer, Kim

Publication type:

Article

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).

Published in:

Neuro-Oncology, 2022, v. 24, p. 1776, doi. 10.1093/neuonc/noac087

By:

Desai, Ami V;
Robinson, Giles W;
Gauvain, Karen;
Basu, Ellen M;
Macy, Margaret E;
Maese, Luke;
Whipple, Nicholas S;
Sabnis, Amit J;
Foster, Jennifer H;
Shusterman, Suzanne;
Yoon, Janet;
Weiss, Brian D;
Abdelbaki, Mohamed S;
Armstrong, Amy E;
Cash, Thomas;
Pratilas, Christine A;
Corradini, Nadège;
Marshall, Lynley V;
Farid-Kapadia, Mufiza;
Chohan, Saibah

Publication type:

Article

Stage 4N neuroblastoma before and during the era of anti‐GD2 immunotherapy.

Published in:

International Journal of Cancer, 2023, v. 153, n. 12, p. 2019, doi. 10.1002/ijc.34693

By:

Kushner, Brian H.;
LaQuaglia, Michael P.;
Cardenas, Fiorella Iglesias;
Basu, Ellen M.;
Gerstle, Justin T.;
Kramer, Kim;
Roberts, Stephen S.;
Wolden, Suzanne L.;
Cheung, Nai‐Kong V.;
Modak, Shakeel

Publication type:

Article

Immunotherapy with anti‐GD2 monoclonal antibody in infants with high‐risk neuroblastoma.

Published in:

International Journal of Cancer, 2023, v. 152, n. 2, p. 259, doi. 10.1002/ijc.34233

By:

Kushner, Brian H.;
Modak, Shakeel;
Kramer, Kim;
Basu, Ellen M.;
Iglesias‐Cardenas, Fiorella;
Roberts, Stephen S.;
Cheung, Nai‐Kong V.

Publication type:

Article

Osteochondroma in long-term survivors of high-risk neuroblastoma.

Published in:

Cancer (0008543X), 2015, v. 121, n. 12, p. 2090, doi. 10.1002/cncr.29316

By:

Kushner, Brian H.;
Roberts, Stephen S.;
Friedman, Danielle N.;
Kuk, Deborah;
Ostrovnaya, Irina;
Modak, Shakeel;
Kramer, Kim;
Basu, Ellen M.;
Cheung, Nai‐Kong V.

Publication type:

Article

Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era.

Published in:

Cancer (0008543X), 2014, v. 120, n. 13, p. 2050, doi. 10.1002/cncr.28687

By:

Kushner, Brian H.;
Modak, Shakeel;
Kramer, Kim;
LaQuaglia, Michael P.;
Yataghene, Karima;
Basu, Ellen M.;
Roberts, Stephen S.;
Cheung, Nai‐Kong V.

Publication type:

Article

Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.

Published in:

2013

By:

Kushner, Brian H;
Modak, Shakeel;
Basu, Ellen M;
Roberts, Stephen S;
Kramer, Kim;
Cheung, Nai-Kong V

Publication type:

journal article

Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.

Published in:

Cancer (0008543X), 2013, v. 119, n. 15, p. 2789, doi. 10.1002/cncr.28137

By:

Kushner, Brian H.;
Modak, Shakeel;
Basu, Ellen M.;
Roberts, Stephen S.;
Kramer, Kim;
Cheung, Nai‐Kong V.

Publication type:

Article

Ifosfamide, carboplatin, and etoposide for neuroblastoma.

Published in:

Cancer (0008543X), 2013, v. 119, n. 3, p. 665, doi. 10.1002/cncr.27783

By:

Kushner, Brian H.;
Modak, Shakeel;
Kramer, Kim;
Basu, Ellen M.;
Roberts, Stephen S.;
Cheung, Nai‐Kong V.

Publication type:

Article

Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.

Published in:

Journal of Neuro-Oncology, 2023, v. 162, n. 1, p. 69, doi. 10.1007/s11060-022-04235-w

By:

Tringale, Kathryn R.;
Wolden, Suzanne L.;
Karajannis, Matthias;
Haque, Sofia;
Pasquini, Luca;
Yildirim, Onur;
Rosenblum, Marc;
Benhamida, Jamal K.;
Cheung, Nai-Kong;
Souweidane, Mark;
Basu, Ellen M.;
Pandit-Taskar, Neeta;
Zanzonico, Pat B.;
Humm, John L.;
Kramer, Kim

Publication type:

Article

Treatment and outcome of adult‐onset neuroblastoma.

Published in:

International Journal of Cancer, 2018, v. 143, n. 5, p. 1249, doi. 10.1002/ijc.31399

By:

Suzuki, Maya;
Kushner, Brian H.;
Kramer, Kim;
Basu, Ellen M.;
Roberts, Stephen S.;
Hammond, William J.;
LaQuaglia, Michael P.;
Wolden, Suzanne L.;
Cheung, Nai‐Kong V.;
Modak, Shakeel

Publication type:

Article

A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma.

Published in:

International Journal of Cancer, 2017, v. 140, n. 2, p. 480, doi. 10.1002/ijc.30440

By:

Kushner, Brian H.;
Cheung, Nai‐Kong V.;
Modak, Shakeel;
Becher, Oren J.;
Basu, Ellen M.;
Roberts, Stephen S.;
Kramer, Kim;
Dunkel, Ira J.

Publication type:

Article

Long Prime–Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine.

Published in:

Vaccines, 2024, v. 12, n. 6, p. 587, doi. 10.3390/vaccines12060587

By:

Cheung, Irene Y.;
Mauguen, Audrey;
Modak, Shakeel;
Basu, Ellen M.;
Feng, Yi;
Kushner, Brian H.;
Cheung, Nai Kong

Publication type:

Article

Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma.

Published in:

2021

By:

Shahid, Sanam;
Kushner, Brian H.;
Modak, Shakeel;
Basu, Ellen M.;
Rubin, Elyssa M.;
Gundem, Gunes;
Papaemmanuil, Elli;
Roberts, Stephen S.

Publication type:

journal article

An unusual case of opsoclonus‐myoclonus‐ataxia syndrome associated neuroblastoma: High‐risk disease requiring immunotherapy.

Published in:

Pediatric Blood & Cancer, 2020, v. 67, n. 11, p. 1, doi. 10.1002/pbc.28393

By:

Stiefel, Jessica;
Basu, Ellen;
Meyer, Rina;
Kaur, Gurcharanjeet;
Khakoo, Yasmin

Publication type:

Article

Reduced‐dose craniospinal irradiation for central nervous system relapsed neuroblastoma.

Published in:

Pediatric Blood & Cancer, 2020, v. 67, n. 9, p. 1, doi. 10.1002/pbc.28364

By:

Luo, Leo Y.;
Kramer, Kim;
Cheung, Nai‐Kong V.;
Kushner, Brian H.;
Modak, Shakeel;
Basu, Ellen M.;
Roberts, Stephen S.;
Wolden, Suzanne L.

Publication type:

Article

Treatment and revaccination of children with paraneoplastic opsoclonus‐myoclonus‐ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.

Published in:

Pediatric Blood & Cancer, 2020, v. 67, n. 8, p. 1, doi. 10.1002/pbc.28319

By:

Patel, Ami;
Fischer, Cheryl;
Lin, Yi‐Chih;
Basu, Ellen M.;
Kushner, Brian H.;
De Braganca, Kevin;
Khakoo, Yasmin

Publication type:

Article

Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.

Published in:

2020

By:

Luo, Leo Y;
Kramer, Kim;
Cheung, Nai-Kong V;
Kushner, Brian H;
Modak, Shakeel;
Basu, Ellen M;
Roberts, Stephen S;
Wolden, Suzanne L

Publication type:

journal article

Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.

Published in:

2020

By:

Patel, Ami;
Fischer, Cheryl;
Lin, Yi-Chih;
Basu, Ellen M;
Kushner, Brian H;
De Braganca, Kevin;
Khakoo, Yasmin

Publication type:

journal article

Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study.

Published in:

2017

By:

Modak, Shakeel;
Kushner, Brian H.;
Basu, Ellen;
Roberts, Stephen S.;
Cheung, Nai‐Kong V.;
Cheung, Nai-Kong V

Publication type:

journal article

Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy?

Published in:

2016

By:

Modak, Shakeel;
Santopolo, Suzanne;
Chu, Bae;
Basu, Ellen

Publication type:

Letter

Feasibility of Administering High-Dose (131) I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms.

Published in:

2016

By:

Chu, Bae P.;
Horan, Christopher;
Basu, Ellen;
Dauer, Lawrence;
Williamson, Matthew;
Carrasquillo, Jorge A.;
Pandit‐Taskar, Neeta;
Modak, Shakeel

Publication type:

journal article

the sexual division of labor and the organization of family and firm in an overseas Chinese community.

Published in:

American Ethnologist, 1991, v. 18, n. 4, p. 700, doi. 10.1525/ae.1991.18.4.02a00040

By:

BASU, ELLEN OXFELD

Publication type:

Article

Works by Basu, Ellen

Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease.

Evolutionary Strategies AI Addresses Multiple Technical Challenges in Deep Learning Deployment: Proof-of-Principle Demonstration for Neuroblastoma Brain Metastasis Detection.

Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with <sup>131</sup>I-omburtamab for leptomeningeal disease.

Ovarian function in female survivors of high‐risk neuroblastoma.

Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).

Stage 4N neuroblastoma before and during the era of anti‐G<sub>D2</sub> immunotherapy.

Immunotherapy with anti‐G<sub>D2</sub> monoclonal antibody in infants with high‐risk neuroblastoma.

Osteochondroma in long-term survivors of high-risk neuroblastoma.

Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era.

Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.

Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-G<sub>D2</sub> 3F8 monoclonal antibody.

Ifosfamide, carboplatin, and etoposide for neuroblastoma.

Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.

Treatment and outcome of adult‐onset neuroblastoma.

A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma.

Long Prime–Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine.

Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma.

An unusual case of opsoclonus‐myoclonus‐ataxia syndrome associated neuroblastoma: High‐risk disease requiring immunotherapy.

Reduced‐dose craniospinal irradiation for central nervous system relapsed neuroblastoma.

Treatment and revaccination of children with paraneoplastic opsoclonus‐myoclonus‐ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.

Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.

Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.

Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study.

Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy?

Feasibility of Administering High-Dose (131) I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms.

the sexual division of labor and the organization of family and firm in an overseas Chinese community.